TASER CEO, Rick Smith discusses his company's strong Q3 earnings in an exclusive interview with TheStreet's Janet Al-Saad. TASER stock surged over 10 percent in intraday trading on Q3 earnings of $0.14 cents a share which handily beat analyst estimates of $0.09 a share. Robust growth of over 25 percent in the core weapons business was complemented by over 150 percent revenue increases in the AXON body camera and Evidence.com cloud-based evidence management systems. As high-profile law enforcement incidents such as recent events in Ferguson, Missouri have drawn attention to an increased need for evidence transparency, TASER is poised to reap the benefits through its new AXON and Evidence.com offerings. TheStreet's Janet Al-Saad reports from New York.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.